RDKK Aims at Sales of 55.5 Billion Yen in 2014 Driven by Personalized Medicine: President Ogasawara

Makoto Ogasawara, President and CEO, Roche Diagnostics K.K. Makoto Ogasawara, who was appointed president and CEO of Roche Diagnostics K.K. (RDKK) in January, announced at his first press conference held at the Tokyo head office on June 19 the company’s...read more